celecoxib has been researched along with Atrophy in 2 studies
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, KH | 1 |
| Yang, HB | 1 |
| Cheng, HC | 1 |
| Wu, JJ | 1 |
| Sheu, BS | 1 |
| Tang, BD | 1 |
| Zeng, ZR | 1 |
| Hu, PJ | 1 |
1 trial available for celecoxib and Atrophy
| Article | Year |
|---|---|
Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication.
Topics: Aged; Atrophy; beta Catenin; Biomarkers; Blood Urea Nitrogen; Celecoxib; Creatinine; Cyclooxygenase | 2010 |
1 other study available for celecoxib and Atrophy
| Article | Year |
|---|---|
[Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Topics: Animals; Atrophy; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinopr | 2006 |